Cutaneous Leukocytoclastic Vasculitis as a rare adverse event of infliximab in Crohn’s disease: a case report
Oxford Medical Case Reports · 09.05.2026 · 2026 (5)
DOI: 10.1093/omcr/omag067 ↗Kurz gefasst
Fallbericht in der Zeitschrift Oxford Medical Case Reports, online erschienen am 10.05.2026. Verfasst von Houssam El Mourad und 4 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology & Hepatology Department, King Saud University, alyasmmen, street 140, home3-4 Riyadh, Saudi Arabia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Leukocytoclastic vasculitis (LCV) is a rare, immune-mediated small-vessel vasculitis that can be triggered by infections, autoimmune diseases, or medications, including biologic therapies. We present a case of a patient with Crohn’s disease who developed biopsy proven LCV during longterm infliximab therapy. After four years of sustained remission on infliximab, she developed cutaneous palpable purpura affecting the lower extremities. Laboratory evaluation excluded systemic vasculitis, infection, and other secondary causes. Histopathology confirmed leukocytoclastic vasculitis. Discontinuation of infliximab, led to complete resolution of skin lesions. This case underscores the importance of clinician awareness of rare biologic-associated adverse effects and highlights the need for timely recognition and management to prevent systemic involvement.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gastroenterology & Hepatology Department, King Saud University, alyasmmen, street 140, home3-4 Riyadh, Saudi Arabia.
- Pathology Department, King Saud University, Riyadh, Saudi Arabia.
ORCID-Profile: Houssam El Mourad
Zitieren
APA
El Mourad, H., Alsayed, E., Al Doheyan, T., Alomar, Y., & Alharbi, O. (2026). Cutaneous Leukocytoclastic Vasculitis as a rare adverse event of infliximab in Crohn’s disease: a case report. Oxford Medical Case Reports, 2026(5). https://doi.org/10.1093/omcr/omag067
Vancouver
El Mourad H, Alsayed E, Al Doheyan T, Alomar Y, Alharbi O. Cutaneous Leukocytoclastic Vasculitis as a rare adverse event of infliximab in Crohn’s disease: a case report. Oxford Medical Case Reports. 2026;2026(5). doi:10.1093/omcr/omag067
BibTeX
@article{ElMourad2026,
author = {El Mourad, Houssam and Alsayed, Esraa and Al Doheyan, Tamadar and Alomar, Yasser and Alharbi, Othman},
title = {Cutaneous Leukocytoclastic Vasculitis as a rare adverse event of infliximab in Crohn’s disease: a case report},
journal = {Oxford Medical Case Reports},
year = {2026},
volume = {2026},
number = {5},
doi = {10.1093/omcr/omag067}
}
EUVIMED